Skip to content
Disclosery

HCC Manager LLC

Follow

13F filer, CIK 1844818, Chicago, IL

HCC Manager LLC reported $5,561,907 across 1 holding for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004593

Period
2025-03-31
Reported value
$5.56M
Holdings
1
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INARI MED INCexited-2,914,246-$149M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-004593, largest first. % of portfolio is the value over $5,561,907, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 4,673,871 shares; 2024Q2: 4,673,871 shares; 2024Q3: 4,673,871 shares; 2024Q4: 4,673,871 shares; 2025Q1: 4,673,871 shares 4,673,871$5.56M100%0Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INARI MED INCINARI MED INC2,914,246$149Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-004593 base2025-05-12acceptance time not in the bulk data set